These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37560147)

  • 1. I-PreFer Study: A Discrete Choice Experiment to Explore Patient, Caregiver and Pulmonologist Preferences of Idiopathic Pulmonary Fibrosis Pharmacological Treatment Options.
    Hollmen M; Wijsenbeek M; Bromilow T; Smith AB; Mealing S; Lewis D; Galvin L; Jones S; Asijee G; Soulard S; Froidure A
    Patient Prefer Adherence; 2023; 17():1895-1906. PubMed ID: 37560147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. I-PreFer Study: A Questionnaire to Explore Patient, Caregiver and Pulmonologist Preferences of Idiopathic Pulmonary Fibrosis Treatment Options.
    Hollmen M; Bromilow T; Smith AB; Mealing S; Lewis D; Galvin L; Jones S; Pacheco L; Soulard S; Froidure A
    Patient Prefer Adherence; 2023; 17():1621-1639. PubMed ID: 37560148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Study of Patient Preferences for the Treatment of Non-small Cell Lung Cancer in Western China: A Discrete-Choice Experiment.
    Liu F; Hu H; Wang J; Chen Y; Hui S; Hu M
    Front Public Health; 2021; 9():653450. PubMed ID: 33842426
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparing Discrete Choice Experiment with Swing Weighting to Estimate Attribute Relative Importance: A Case Study in Lung Cancer Patient Preferences.
    Veldwijk J; Smith IP; Oliveri S; Petrocchi S; Smith MY; Lanzoni L; Janssens R; Huys I; de Wit GA; Groothuis-Oudshoorn CGM
    Med Decis Making; 2024 Feb; 44(2):203-216. PubMed ID: 38178591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expectations about treatment of idiopathic pulmonary fibrosis: Comparative survey of patients, carers and physicians (the RESPIR French survey).
    Cottin V; Bergot E; Bourdin A; Nunes H; Prévot G; Wallaert B; Marchand-Adam S
    Respir Med Res; 2021 May; 79():100811. PubMed ID: 33618076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment preferences of patients with relapsed or refractory multiple myeloma in the United States, United Kingdom, Italy, Germany, France, and Spain: results from a discrete choice experiment.
    Thomas C; Ailawadhi S; Popat R; Kleinman D; Ross MM; Gorsh B; Mulnick S; O'Neill A; Paka P; Hanna M; Krucien N; Molinari A; Gelhorn HL; Perera S
    Front Med (Lausanne); 2023; 10():1271657. PubMed ID: 38076274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative importance of clinical outcomes and safety risks of antiseizure medication monotherapy for patients and physicians: Discrete choice experiment eliciting preferences in real-world study "VOTE".
    Rosenow F; Winter Y; Leunikava I; Brunnert M; Joeres L; Sutphin J; Boeri M; Smith J; Villani F; Brandt C
    Epilepsia; 2022 Feb; 63(2):451-462. PubMed ID: 34921391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physician characteristics associated with treatment initiation patterns in idiopathic pulmonary fibrosis.
    LaCamera PP; Limb SL; Haselkorn T; Morgenthien EA; Stauffer JL; Wencel ML
    Chron Respir Dis; 2019; 16():1479973119879678. PubMed ID: 31558049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient and caregiver preferences for haemophilia A treatments: A discrete choice experiment.
    Su J; Li N; Joshi N; Ng X; Botteman M; Shah R; Jain N; Lyn N; Preblick R
    Haemophilia; 2020 Nov; 26(6):e291-e299. PubMed ID: 32937681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient and Caregiver Treatment Preferences in Type 2 and Non-ambulatory Type 3 Spinal Muscular Atrophy: A Discrete Choice Experiment Survey in Five European Countries.
    Lo SH; Lawrence C; Martí Y; Café A; Lloyd AJ
    Pharmacoeconomics; 2022 Apr; 40(Suppl 1):103-115. PubMed ID: 34897574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding Clinician Preferences for Treatment Attributes in Oncology: A Discrete Choice Experiment of Oncologists' and Urologists' Preferences for First-Line Treatment of Locally Advanced/Unresectable Metastatic Urothelial Carcinoma in Five European Countries.
    Panattoni L; Kearney M; Land N; Flottemesch T; Sullivan P; Kirker M; Bharmal M; Hauber B
    Pharmacoeconomics; 2024 Aug; 42(8):895-909. PubMed ID: 38472738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drivers of patient and caregiver preferences for growth hormone deficiency treatments in France: a discrete choice experiment.
    Polak M; Demaret B; Henocque R; Chachoua L; Aballea S; Mezghani M; La Torre D; Salvi L; Touraine P
    Horm Res Paediatr; 2023 Nov; ():. PubMed ID: 38029732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translating Idiopathic pulmonary fibrosis guidelines into clinical practice.
    Robalo-Cordeiro C; Morais A
    Pulmonology; 2021; 27(1):7-13. PubMed ID: 32561352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying Barriers to Idiopathic Pulmonary Fibrosis Treatment: A Survey of Patient and Physician Views.
    Maher TM; Swigris JJ; Kreuter M; Wijsenbeek M; Cassidy N; Ireland L; Axmann J; Nathan SD
    Respiration; 2018; 96(6):514-524. PubMed ID: 30114692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient and General Population Preferences Regarding the Benefits and Harms of Treatment for Metastatic Prostate Cancer: A Discrete Choice Experiment.
    Menges D; Piatti MC; Omlin A; Cathomas R; Benamran D; Fischer S; Iselin C; Küng M; Lorch A; Prause L; Rothermundt C; O'Meara Stern A; Zihler D; Lippuner M; Braun J; Cerny T; Puhan MA
    Eur Urol Open Sci; 2023 May; 51():26-38. PubMed ID: 37187724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dyadic Discrete Choice Experiments Enable Persons with Dementia and Informal Caregivers to Participate in Health Care Decision Making: A Mixed Methods Study.
    Wammes JD; Swait JD; de Bekker-Grob EW; Monin JK; Labrie NHM; MacNeil Vroomen JL
    J Alzheimers Dis; 2023; 91(1):105-114. PubMed ID: 36373319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient Preferences for Treatment Attributes in Inflammatory Bowel Disease: Results From a Large Survey Across Seven European Countries Using a Discrete Choice Experiment.
    Fiorino G; Bent-Ennakhil N; Varriale P; Braegger F; Hoefkens E
    Inflamm Bowel Dis; 2024 Dec; 30(12):2380-2394. PubMed ID: 38503480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alignment of preferences in the treatment of multiple myeloma - a discrete choice experiment of patient, carer, physician, and nurse preferences.
    Fifer SJ; Ho KA; Lybrand S; Axford LJ; Roach S
    BMC Cancer; 2020 Jun; 20(1):546. PubMed ID: 32527324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient Preferences for Lung Cancer Treatments: A Study Protocol for a Preference Survey Using Discrete Choice Experiment and Swing Weighting.
    Monzani D; Petrocchi S; Oliveri S; Veldwijk J; Janssens R; Bailo L; Smith MY; Smith I; Schoefs E; Nackaerts K; Vandevelde M; Louis E; Decaluwé H; De Leyn P; Declerck H; Katz EG; Petrella F; Casiraghi M; Durosini I; Galli G; Garassino MC; de Wit GA; Pravettoni G; Huys I
    Front Med (Lausanne); 2021; 8():689114. PubMed ID: 34409049
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.